The pediatric multisystem inflammatory syndrome [hereinafter MIS-C for its acronym in English] is a serious condition that results in inflammation of some organs of the body such as the heart, lungs, kidneys, digestive system, brain, skin, eyes and even Blood vesels. Data and research from the Centers for Disease Control and Prevention indicate that most children with MIS-C have previously been infected with the COVID-19 virus.

Experts point out that MIS-C is an excessive immune response directly related to the coronavirus. Among the most common affecting signs presented by pediatric patients with MIS-C are the following:

• Inability to wake up or stay awake
• Difficulty breathing
• sudden confusion
• Pale, grayish, or bluish skin, lips, or nail bed, depending on skin tone
• severe stomach pain

MIS-C is a rare complication of COVID-19, however it can be dangerous if not treated early. Symptoms can overlap with infections and other illnesses. Children showing these symptoms should be seen by a doctor. It affects school-age children, between 8 and 9 years old, but has also been seen in infants and young adults. 

MIS-C symptoms appear between the second and sixth week after COVID-19 infection. Most children with MIS-C have antibodies against the SARS-CoV-2 virus. MIS-C is a treatable condition and most children make a full recovery after this illness. With early attention, medication, and care, inflammation can be controlled and damage to organs, especially your heart, can be prevented.

https://www.instagram.com/p/CbGBL7Cgxm5/